Eli Lilly, a major pharmaceutical company, announced today that it will follow President Joe Biden and Democrats’ lead and cap the cost of its insulin at $35 a month, no thanks to a single congressional Republican.

Every single Republican in Congress voted AGAINST the Inflation Reduction Act — historic legislation that caps the cost of insulin for seniors on Medicare at $35 a month.

Rolling Stone: “House Democrats Pass Historic Climate, Healthcare Bill over Republican Opposition”

Let’s not forget: GOP senators actually went out of their way to strip out a provision from the Inflation Reduction Act that also would have capped the cost of insulin at $35 a month for Americans on private insurance.

Washington Post: “GOP senators move to strip a $35 price cap on insulin under private insurance from the Inflation Reduction Act”

NBC: “Republicans block cap on insulin costs for many Americans from Democratic deal”

House Republicans introduced a bill and have called to repeal the Inflation Reduction Act — an action that would raise prescription drug costs on millions of Americans.

Rep. Andy Ogles: “I just introduced the Inflation Reduction Act of 2023 which would reduce inflation by REPEALING the Democrats’ Inflation Reduction Act of 2022.”

Axios: “Some key House Republicans are calling for the repeal of Democrats’ newly-passed drug pricing measure if the GOP flips control of one or both chambers of Congress next year.”

Rep. Buddy Carter: “With the prescription drug pricing, that’s something I’m very interested in as a pharmacist. And I’ve been asking my colleagues ‘how are we going to undo that when we get into the majority?’”

CNBC: “Medicare is poised to renegotiate the prices of some of its most expensive drugs through a historic expansion of its power, which could reduce costs for many seniors as well as federal spending on its prescription drug plan.”

As president, Donald Trump repeatedly promised to bring down the cost of insulin — and failed.

CNBC: “Eli Lilly CEO rebuffs Trump’s attack on drug prices”

Washington Post: “Trump boasted he made insulin so cheap ‘it’s like water.’ Americans with diabetes beg to differ.”